Synopsis Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. The company serves a worldwide customer base which spans to the United States, Europe, and Japan. Wall Street behemoth Goldman Sachs has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences, a leading contract research organization (CRO), the company announced today. Goldman Sachs, an active investor in India, has acquired shares previously held by ChrysCapital and other existing shareholders. The priva...